Skip to content
November 19, 2025
  • With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis
  • Pyx Health Introduces Platform to Support Those Affected by OBBBA
  • Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins
  • How to get whatever you want

Medical Article

Newsletter
Random News
  • Sample Page
Headlines
  • With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis

    1 hour ago
  • Pyx Health Introduces Platform to Support Those Affected by OBBBA

    3 hours ago
  • Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins

    8 hours ago
  • How to get whatever you want

    9 hours ago
  • The Most Scientifically Advanced Cryopreservation Techniques: Alcor at the Forefront

    10 hours ago
  • Struggling UnitedHealth Group is a Huge Smoking Black Box

    12 hours ago
  • Home
  • Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
  • Medicine

Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023

9 months ago01 mins

Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 2023.

The post Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023 appeared first on MedCity News.

Post navigation

Previous: The New Reality of Hospital-Payer Contracts: How Baptist Health Negotiated with Florida Blue
Next: More evidence that there are diminishing marginal returns to quality of life gains

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis

1 hour ago 0

Pyx Health Introduces Platform to Support Those Affected by OBBBA

3 hours ago 0

The Most Scientifically Advanced Cryopreservation Techniques: Alcor at the Forefront

10 hours ago 0

USA’s Best Fixed-Wing Air Ambulance Services: Features, Coverage and Reviews

12 hours ago 0

Recent Posts

  • With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis
  • Pyx Health Introduces Platform to Support Those Affected by OBBBA
  • Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins
  • How to get whatever you want
  • The Most Scientifically Advanced Cryopreservation Techniques: Alcor at the Forefront

Recent Comments

No comments to show.

Archives

  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other
Newsmatic - News WordPress Theme 2025. Powered By BlazeThemes.